Who owns MNLO - MENLO THERAPEUTICS INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

MENLO THERAPEUTICS INC - COM (MNLO) Institutional Ownership

Q: What is CUSIP 586858102?

CUSIP 586858102 is the security identifier used in SEC filing datasets for MNLO - MENLO THERAPEUTICS INC - COM.

CUSIP: 586858102

13F Institutional Holders and Ownership History from Q1 2018 to Q3 2020

Type / Class: Equity / COM
Symbol: MNLO

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 586858102?
CUSIP 586858102 identifies MNLO - MENLO THERAPEUTICS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 586858102:

Q3 2020 (0 holders) Q2 2020 (100 holders) Q1 2020 (90 holders) Q4 2019 (52 holders) Q3 2019 (54 holders) Q2 2019 (56 holders) Q1 2019 (58 holders) Q4 2018 (54 holders) Q3 2018 (51 holders) Q2 2018 (46 holders)

Institutional Holders of MENLO THERAPEUTICS INC - COM (MNLO) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2020 Q3	0	$0	-$144,522,843				0
2020 Q2	83,515,779	$144,532,313	+$78,079,397	$0	$0	$1.73	100
2020 Q1	34,654,915	$92,541,279	+$45,559,007	$176,000	$160,000	$2.68	90
2019 Q4	13,860,758	$64,308,386	-$844,567			$4.64	52
2019 Q3	14,069,423	$63,031,611	-$25,349,271			$4.48	54
2019 Q2	18,330,610	$109,536,399	+$3,882,364			$5.99	56
2019 Q1	17,695,152	$138,908,540	+$13,516,413			$7.85	58
2018 Q4	18,052,300	$74,373,566	-$4,433,183			$4.12	54
2018 Q3	16,310,413	$160,655,990	+$24,813,495			$9.85	51
2018 Q2	14,257,728	$115,953,908	-$55,051,648			$8.12	46
2018 Q1	15,417,446	$579,384,292	+$579,384,292			$37.58	49